bf/NYSE:HAE_icon.png

COM:HAEMONETICS

Haemonetics Corporation

  • Stock

Last Close

84.92

21/11 21:00

Market Cap

4.44B

Beta: -

Volume Today

478.86K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Apr '16
Apr '17
Mar '18
Mar '19
Mar '20
Apr '21
Apr '22
Apr '23
Mar '24
Mar '24
average inventory
190.72M
-
204.37M
7.16%
198.61M
2.82%
181.54M
8.60%
168.86M
6.98%
177.57M
5.15%
232.31M
30.83%
296.44M
27.61%
307.82M
3.84%
276.20M
10.27%
288.29M
4.38%
288.29M
0%
average payables
51.73M
-
50.99M
1.42%
44.05M
13.62%
41.32M
6.19%
49.12M
18.86%
59.31M
20.75%
57.05M
3.82%
50.51M
11.45%
54.33M
7.56%
61.15M
12.55%
68.64M
12.25%
31.96M
53.43%
average receivables
167.54M
-
155.39M
7.25%
151.46M
2.53%
154.89M
2.26%
151.95M
1.89%
168.13M
10.64%
175.12M
4.16%
146.38M
16.41%
143.47M
1.99%
169.26M
17.98%
192.85M
13.94%
192.85M
0%
book value per share
16.27
-
16.03
1.46%
14.14
11.78%
14.35
1.50%
14.26
0.64%
12.96
9.13%
11.58
10.63%
14.43
24.63%
14.68
1.71%
16.11
9.72%
18.93
17.53%
18.93
0%
capex per share
-1.43
-
-2.37
66.20%
-2.01
15.19%
-1.48
26.54%
-1.42
4.05%
-2.31
62.81%
-0.96
58.33%
-0.73
24.03%
-1.89
158.72%
-2.17
14.77%
-6.12
181.89%
-6.12
0%
capex to depreciation
-0.90
-
-1.42
57.63%
-1.14
19.92%
-0.85
25.40%
-0.84
1.22%
-1.09
29.72%
-0.44
59.34%
-0.44
0.60%
-0.99
124.67%
-1.18
19.61%
-2.40
103.20%
-2.40
0%
capex to operating cash flow
-0.53
-
-0.96
82.06%
-0.84
12.56%
-0.48
43.28%
-0.34
28.78%
-0.75
120.02%
-0.31
58.74%
-0.34
10.47%
-0.56
64.57%
-0.40
27.97%
-1.71
322.86%
-1.71
0%
capex to revenue
-0.08
-
-0.13
71.08%
-0.11
16.15%
-0.09
23.68%
-0.08
3.69%
-0.12
48.58%
-0.05
59.88%
-0.04
13.73%
-0.10
128.36%
-0.09
2.97%
-0.24
151.28%
-0.24
0%
cash per share
3.73
-
3.12
16.40%
2.26
27.47%
2.71
19.79%
3.42
26.08%
3.29
3.78%
2.71
17.57%
3.79
40.06%
5.08
33.99%
5.60
10.19%
3.53
37.05%
3.53
0%
days of inventory on hand
153.46
-
161.87
5.48%
134.86
16.69%
127.22
5.67%
119.29
6.23%
128.96
8.11%
195.75
51.79%
249.15
27.28%
219.31
11.98%
171.03
22.02%
183.05
7.03%
183.05
0%
days payables outstanding
41.58
-
37.14
10.69%
28.74
22.60%
30.90
7.50%
41.00
32.68%
42.05
2.55%
36.74
12.61%
38.84
5.71%
43.69
12.48%
42.15
3.51%
42.33
0.43%
days sales outstanding
64.16
-
58.47
8.87%
63.03
7.81%
62.89
0.22%
61.06
2.91%
69.80
14.30%
61.00
12.60%
53.49
12.32%
58.57
9.51%
55.95
4.47%
57.60
2.94%
57.60
0%
debt to assets
0.29
-
0.29
0.25%
0.31
7.37%
0.25
18.00%
0.21
19.29%
0.27
33.96%
0.30
9.91%
0.39
28.80%
0.42
6.98%
0.40
4.84%
0.37
7.05%
0.37
0%
debt to equity
0.52
-
0.52
0.64%
0.57
9.41%
0.43
24.93%
0.34
20.75%
0.52
55.49%
0.65
24.27%
0.97
48.45%
1.03
6.73%
0.94
9.30%
0.84
10.13%
0.84
0%
dividend yield
earnings yield
0.02
-
0.01
65.03%
-0.03
517.42%
-0.01
59.41%
0.01
193.96%
0.01
3.36%
0.01
22.53%
0.01
6.43%
0.01
4.90%
0.03
106.35%
0.03
1.08%
0.03
0.66%
enterprise value
1.90B
-
2.55B
33.80%
2.09B
17.91%
2.27B
8.42%
3.93B
73.61%
4.69B
19.22%
5.36B
14.37%
6.19B
15.51%
3.77B
39.08%
4.68B
24.12%
4.96B
5.83%
4.93B
0.57%
enterprise value over ebitda
40.20
-
62.79
56.20%
16.53
73.67%
17.57
6.26%
27.05
53.96%
24.30
10.17%
20.29
16.48%
43.55
114.57%
22.27
48.87%
18.78
15.64%
15.51
17.44%
15.42
0.57%
ev to operating cash flow
13.64
-
20.02
46.79%
17.15
14.34%
14.18
17.29%
17.85
25.86%
29.44
64.92%
33.89
15.14%
56.93
67.97%
21.91
61.52%
17.15
21.69%
27.27
59.00%
27.12
0.57%
ev to sales
2.03
-
2.80
37.94%
2.30
17.85%
2.56
11.30%
4.35
70.19%
4.85
11.37%
5.43
11.95%
7.12
31.17%
3.80
46.61%
4.01
5.49%
3.79
5.52%
3.76
0.57%
free cash flow per share
1.28
-
0.10
92.46%
0.38
297.30%
1.62
324.49%
2.76
70.04%
0.78
71.64%
2.16
175.98%
1.42
34.43%
1.48
4.82%
3.21
116.11%
-2.53
178.96%
-2.53
0%
free cash flow yield
0.04
-
0.00
94.53%
0.01
397.72%
0.04
269.25%
0.04
5.71%
0.01
76.28%
0.02
139.15%
0.01
40.92%
0.02
83.92%
0.04
66.75%
-0.03
176.55%
-0.03
0.66%
graham net net
-5.16
-
-5.46
5.87%
-5.33
2.49%
-3.04
42.94%
-2.10
30.80%
-3.91
86.07%
-5.60
43.03%
-12.61
125.29%
-11.46
9.13%
-11.19
2.31%
-14.66
30.99%
-14.66
0%
graham number
15.79
-
10.88
31.12%
18.65
71.45%
12.83
31.18%
16.65
29.75%
17.64
5.97%
19.83
12.41%
22.57
13.77%
16.75
25.76%
28.70
71.30%
31.43
9.50%
31.43
0%
income quality
3.97
-
7.53
89.61%
-2.19
129.11%
-6.08
177.54%
4.84
179.51%
2.90
40.13%
2.07
28.58%
1.37
33.78%
3.97
190.07%
2.37
40.42%
1.55
34.66%
1.55
0%
intangibles to total assets
0.40
-
0.39
2.35%
0.36
8.13%
0.31
12.56%
0.30
5.15%
0.27
10.71%
0.27
2.16%
0.46
68.50%
0.42
8.54%
0.38
8.28%
0.44
15.34%
0.26
41.82%
interest coverage
4.33
-
4.32
0.17%
-4.64
207.36%
-2.39
48.43%
12.41
618.35%
8.43
32.08%
9.50
12.75%
3.44
63.77%
4.72
36.98%
10.67
126.13%
-14.62
237.10%
-14.62
0%
interest debt per share
8.69
-
8.49
2.38%
8.20
3.36%
6.26
23.61%
4.89
21.86%
6.99
42.74%
7.86
12.58%
14.29
81.72%
15.49
8.38%
15.37
0.78%
15.67
1.98%
15.67
0%
inventory turnover
2.38
-
2.25
5.20%
2.71
20.03%
2.87
6.01%
3.06
6.65%
2.83
7.50%
1.86
34.12%
1.46
21.43%
1.66
13.61%
2.13
28.23%
1.99
6.57%
1.99
0%
invested capital
0.52
-
0.52
0.64%
0.57
9.41%
0.43
24.93%
0.34
20.75%
0.52
55.49%
0.65
24.27%
0.97
48.45%
1.03
6.73%
0.94
9.30%
0.84
10.13%
0.84
0%
market cap
1.66B
-
2.28B
37.47%
1.80B
21.14%
2.09B
16.35%
3.86B
84.64%
4.51B
16.80%
5.12B
13.51%
5.68B
10.98%
3.26B
42.61%
4.20B
28.93%
4.33B
2.99%
4.30B
0.66%
net current asset value
-51.59M
-
-89.02M
72.56%
-109.92M
23.49%
10.93M
109.94%
36.27M
231.81%
-30.78M
184.87%
-76.36M
148.11%
-394.71M
416.89%
-354.28M
10.24%
-347.11M
2.02%
-466.73M
34.46%
-466.73M
0%
net debt to ebitda
5.18
-
6.59
27.22%
2.32
64.84%
1.36
41.41%
0.51
62.77%
0.94
85.29%
0.93
0.95%
3.62
290.41%
3.03
16.26%
1.93
36.35%
1.97
1.93%
1.97
0%
net income per share
0.68
-
0.33
51.85%
-1.09
433.20%
-0.51
53.34%
0.86
269.44%
1.07
23.59%
1.51
41.40%
1.57
3.85%
0.85
45.80%
2.27
167.44%
2.32
2.02%
2.32
0%
operating cash flow per share
2.70
-
2.47
8.71%
2.39
3.01%
3.10
29.52%
4.18
34.73%
3.09
26.00%
3.12
0.98%
2.15
31.23%
3.37
57.21%
5.38
59.34%
3.58
33.34%
3.58
0%
payables turnover
8.78
-
9.83
11.98%
12.70
29.20%
11.81
6.98%
8.90
24.63%
8.68
2.49%
9.93
14.44%
9.40
5.40%
8.36
11.09%
8.66
3.64%
8.62
0.43%
receivables turnover
5.69
-
6.24
9.73%
5.79
7.24%
5.80
0.22%
5.98
2.99%
5.23
12.51%
5.98
14.42%
6.82
14.05%
6.23
8.68%
6.52
4.68%
6.34
2.86%
6.34
0%
research and ddevelopement to revenue
0.06
-
0.06
3.07%
0.05
15.85%
0.04
15.39%
0.04
2.39%
0.04
14.95%
0.03
15.36%
0.04
20.82%
0.05
24.84%
0.04
8.97%
0.04
3.06%
0.04
0%
return on tangible assets
0.04
-
0.02
51.46%
-0.07
452.32%
-0.03
53.08%
0.05
269.69%
0.06
12.10%
0.08
41.03%
0.08
2.95%
0.04
50.17%
0.10
141.38%
0.10
0.76%
0.07
24.91%
revenue per share
18.18
-
17.67
2.85%
17.87
1.15%
17.20
3.75%
17.13
0.37%
18.78
9.58%
19.50
3.85%
17.17
11.93%
19.46
13.30%
23.01
18.28%
25.82
12.18%
25.82
0%
roe
0.04
-
0.02
51.14%
-0.08
477.70%
-0.04
54.03%
0.06
270.53%
0.08
36.02%
0.13
58.22%
0.11
16.67%
0.06
46.71%
0.14
143.75%
0.12
13.20%
0.12
0%
roic
0.04
-
0.02
51.01%
-0.04
331.47%
-0.02
56.68%
0.04
342.70%
0.06
43.76%
0.13
114.25%
0.04
68.15%
0.04
14.02%
0.08
123.50%
0.08
3.68%
0.08
0%
sales general and administrative to revenue
shareholders equity per share
16.27
-
16.03
1.46%
14.14
11.78%
14.35
1.50%
14.26
0.64%
12.96
9.13%
11.58
10.63%
14.43
24.63%
14.68
1.71%
16.11
9.72%
18.93
17.53%
18.93
0%
stock based compensation to revenue
0.01
-
0.02
11.08%
0.01
50.66%
0.01
35.17%
0.01
39.55%
0.02
23.28%
0.02
16.49%
0.03
41.66%
0.02
16.33%
0.02
10.74%
0.02
1.13%
0.02
0%
tangible asset value
231.69M
-
247.22M
6.71%
247.68M
0.18%
351.23M
41.81%
384.44M
9.46%
329.36M
14.33%
243.35M
26.11%
-100.26M
141.20%
-28.12M
71.95%
76.00M
370.21%
-11.24M
114.79%
394.88M
3,613.14%
tangible book value per share
4.49
-
4.80
6.87%
4.87
1.41%
6.82
40.12%
7.29
6.90%
6.39
12.30%
4.80
24.89%
-1.98
141.20%
-0.55
72.15%
1.50
371.62%
-0.22
114.81%
7.79
3,613.14%
working capital
411.83M
-
378.89M
8.00%
302.49M
20.16%
298.85M
1.20%
136.47M
54.33%
340.36M
149.40%
319.34M
6.18%
440.05M
37.80%
313.76M
28.70%
517.91M
65.06%
468.52M
9.54%
468.52M
0%

All numbers in (except ratios and percentages)